BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34636428)

  • 1. Islet amyloid toxicity: From genesis to counteracting mechanisms.
    Marmentini C; Branco RCS; Boschero AC; Kurauti MA
    J Cell Physiol; 2022 Feb; 237(2):1119-1142. PubMed ID: 34636428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.
    Akter R; Cao P; Noor H; Ridgway Z; Tu LH; Wang H; Wong AG; Zhang X; Abedini A; Schmidt AM; Raleigh DP
    J Diabetes Res; 2016; 2016():2798269. PubMed ID: 26649319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
    Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
    Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity.
    Abedini A; Cao P; Plesner A; Zhang J; He M; Derk J; Patil SA; Rosario R; Lonier J; Song F; Koh H; Li H; Raleigh DP; Schmidt AM
    J Clin Invest; 2018 Feb; 128(2):682-698. PubMed ID: 29337308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IAPP amyloidogenic properties and pancreatic β-cell death.
    Fernández MS
    Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP).
    Sequeira IR; Poppitt SD
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28754022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes.
    Blencowe M; Furterer A; Wang Q; Gao F; Rosenberger M; Pei L; Nomoto H; Mawla AM; Huising MO; Coppola G; Yang X; Butler PC; Gurlo T
    Diabetologia; 2022 Jan; 65(1):173-187. PubMed ID: 34554282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The β-cell assassin: IAPP cytotoxicity.
    Raleigh D; Zhang X; Hastoy B; Clark A
    J Mol Endocrinol; 2017 Oct; 59(3):R121-R140. PubMed ID: 28811318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet amyloid polypeptide and type 2 diabetes.
    Marzban L; Park K; Verchere CB
    Exp Gerontol; 2003 Apr; 38(4):347-51. PubMed ID: 12670620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic stress, IAPP and islet amyloid.
    Montane J; Klimek-Abercrombie A; Potter KJ; Westwell-Roper C; Bruce Verchere C
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():68-77. PubMed ID: 22928566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
    Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
    Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models.
    Wirth F; Heitz FD; Seeger C; Combaluzier I; Breu K; Denroche HC; Thevenet J; Osto M; Arosio P; Kerr-Conte J; Verchere CB; Pattou F; Lutz TA; Donath MY; Hock C; Nitsch RM; Grimm J
    Nat Commun; 2023 Oct; 14(1):6294. PubMed ID: 37813862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.